182 related articles for article (PubMed ID: 11762336)
1. Clinical significance of neuroendocrine carcinoma of the breast.
Sapino A; Papotti M; Righi L; Cassoni P; Chiusa L; Bussolati G
Ann Oncol; 2001; 12 Suppl 2():S115-7. PubMed ID: 11762336
[TBL] [Abstract][Full Text] [Related]
2. Expression of apocrine differentiation markers in neuroendocrine breast carcinomas of aged women.
Sapino A; Righi L; Cassoni P; Papotti M; Gugliotta P; Bussolati G
Mod Pathol; 2001 Aug; 14(8):768-76. PubMed ID: 11504836
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical analysis of pleomorphic lobular carcinoma: higher expression of p53 and chromogranin and lower expression of ER and PgR.
Radhi JM
Histopathology; 2000 Feb; 36(2):156-60. PubMed ID: 10672061
[TBL] [Abstract][Full Text] [Related]
4. Estrogen and progesterone receptors and anti-gross cystic disease fluid protein 15 (BRST-2) fail to distinguish metastatic breast carcinoma from eccrine neoplasms.
Wallace ML; Longacre TA; Smoller BR
Mod Pathol; 1995 Dec; 8(9):897-901. PubMed ID: 8751328
[TBL] [Abstract][Full Text] [Related]
5. Neuroendocrine differentiation in pure type mammary mucinous carcinoma is associated with favorable histologic and immunohistochemical parameters.
Tse GM; Ma TK; Chu WC; Lam WW; Poon CS; Chan WC
Mod Pathol; 2004 May; 17(5):568-72. PubMed ID: 15001999
[TBL] [Abstract][Full Text] [Related]
6. Expression of GCDFP-15 and AR decreases in larger or node-positive apocrine carcinomas of the breast.
Honma N; Takubo K; Akiyama F; Sawabe M; Arai T; Younes M; Kasumi F; Sakamoto G
Histopathology; 2005 Aug; 47(2):195-201. PubMed ID: 16045781
[TBL] [Abstract][Full Text] [Related]
7. Expression of GCDFP-15 in breast carcinomas. Relationship to pathologic and clinical factors.
Mazoujian G; Bodian C; Haagensen DE; Haagensen CD
Cancer; 1989 Jun; 63(11):2156-61. PubMed ID: 2655863
[TBL] [Abstract][Full Text] [Related]
8. Neuroendocrine differentiation correlates with hormone receptor expression and decreased survival in patients with invasive breast carcinoma.
Kwon SY; Bae YK; Gu MJ; Choi JE; Kang SH; Lee SJ; Kim A; Jung HR; Kang SH; Oh HK; Park JY
Histopathology; 2014 Apr; 64(5):647-59. PubMed ID: 24117859
[TBL] [Abstract][Full Text] [Related]
9. PIP/GCDFP-15 gene expression and apocrine differentiation in carcinomas of the breast.
Pagani A; Sapino A; Eusebi V; Bergnolo P; Bussolati G
Virchows Arch; 1994; 425(5):459-65. PubMed ID: 7850069
[TBL] [Abstract][Full Text] [Related]
10. Differential sensitivity of estrogen/progesterone receptors and BRST-2 markers in metastatic ductal and lobular breast carcinoma to the skin.
Wallace ML; Smoller BR
Am J Dermatopathol; 1996 Jun; 18(3):241-7. PubMed ID: 8806958
[TBL] [Abstract][Full Text] [Related]
11. Primary signet ring cell carcinoma of the eyelid: report of a case demonstrating further analogy to lobular carcinoma of the breast with a literature review.
Langel DJ; Yeatts RP; White WL
Am J Dermatopathol; 2001 Oct; 23(5):444-9. PubMed ID: 11801778
[TBL] [Abstract][Full Text] [Related]
12. [Immunohistochemical comparison between GCDFP-15 and estrogen and progesterone receptors in the diagnosis of metastatic carcinoma of the breast].
Villarroel Salinas J; Ortiz Hidalgo C; Soria Céspedes D
Gac Med Mex; 2012; 148(3):213-7. PubMed ID: 22820353
[TBL] [Abstract][Full Text] [Related]
13. Estrogen and progesterone receptors in breast cancer.
Couch P
Am J Dermatopathol; 1997 Oct; 19(5):553-5. PubMed ID: 9335253
[No Abstract] [Full Text] [Related]
14. Progesterone-binding cyst protein (PBCP = GCDFP-24) and steroid hormone receptors as markers of differentiation in breast cancer. Inverse relation of distribution in normal and malignant tissue of the same breast.
Søreide JA; Lea OA; Kvinnsland S
Anticancer Res; 1991; 11(3):1323-6. PubMed ID: 1888167
[TBL] [Abstract][Full Text] [Related]
15. Occult breast carcinoma presenting with axillary lymph node metastases: follow-up of eleven patients.
Matsuoka K; Ohsumi S; Takashima S; Saeki T; Aogi K; Mandai K
Breast Cancer; 2003; 10(4):330-4. PubMed ID: 14634511
[TBL] [Abstract][Full Text] [Related]
16. Neuroendocrine carcinomas of the breast.
Rovera F; Masciocchi P; Coglitore A; La Rosa S; Dionigi G; Marelli M; Boni L; Dionigi R
Int J Surg; 2008; 6 Suppl 1():S113-5. PubMed ID: 19167937
[TBL] [Abstract][Full Text] [Related]
17. Homologous carcinomas of the breasts, skin, and salivary glands. A histologic and immunohistochemical comparison of ductal mammary carcinoma, ductal sweat gland carcinoma, and salivary duct carcinoma.
Wick MR; Ockner DM; Mills SE; Ritter JH; Swanson PE
Am J Clin Pathol; 1998 Jan; 109(1):75-84. PubMed ID: 9426521
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of neuroendocrine phenotype in non-small-cell lung cancer.
Carnaghi C; Rimassa L; Garassino I; Santoro A
Ann Oncol; 2001; 12 Suppl 2():S119-23. PubMed ID: 11762337
[TBL] [Abstract][Full Text] [Related]
19. Value of gross cystic disease fluid protein-15 in distinguishing metastatic breast carcinomas among poorly differentiated neoplasms involving the ovary.
Monteagudo C; Merino MJ; LaPorte N; Neumann RD
Hum Pathol; 1991 Apr; 22(4):368-72. PubMed ID: 2050370
[TBL] [Abstract][Full Text] [Related]
20. Prostate-specific antigen and gross cystic disease fluid protein-15 are co-expressed in androgen receptor-positive breast tumours.
Hall RE; Clements JA; Birrell SN; Tilley WD
Br J Cancer; 1998 Aug; 78(3):360-5. PubMed ID: 9703283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
